Pharmaceutical company RV Healthcare to invest in Uzbekistan

RV Healthcare (Singapore), one of Asia’s largest pharmaceutical groups, has launched a major investment in Uzbekistan.

The project will involve the creation of a distribution centre for more than 40 types of drugs by 2018, followed in 2019-2020 by the transfer of technologies for the production and packaging of hi-tech antiviral drugs (hepatitis B and C and antiretroviral drugs), oral cancer drugs, injections and biostimulators.

The third step in 2021-2022 will involve the start-up of complete cycle pharmaceutical production. RV Healthcare has production facilities in India, Vietnam, Myanmar, China, Cambodia, Hong Kong, UK, Thailand, Kazakhstan and the Philippines.